REQUEST A DEMO
Total
USD $0.00
Search more companies

Krt Pharma Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Department Stores | Electronic Shopping and Mail-Order Houses | All Other Nondepository Credit Intermediation | Advertising Agencies
Full name: Krt Pharma Sp. z o.o. Profile Updated: May 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Krt Pharma Sp. z o.o. is based in Poland. The head office is in Warsaw. It operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on April 26, 2019. From the latest financial highlights, Krt Pharma Sp. z o.o. reported a net sales revenue increase of 4.03% in 2022. Its’ total assets recorded a growth of 50.5%. Krt Pharma Sp. z o.o.’s net profit margin increased by 13.7% in 2022.

Headquarters
Ul. Romualda Mielczarskiego 10/9
Warsaw; Mazowieckie; Postal Code: 02-798

Contact Details: Purchase the Krt Pharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Krt Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Krt Pharma Sp. z o.o. report to view the information.
Incorporation Date:
April 26, 2019
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
99%
Company Performance
Financial values in the chart are available after Krt Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
4.03%
Total operating revenue
4.98%
Operating profit (EBIT)
18.97%
Net Profit (Loss) for the Period
27.4%
Total assets
50.5%
Total equity
3198.34%
Operating Profit Margin (ROS)
10.44%
Net Profit Margin
13.7%
Return on Equity (ROE)
-1352.86%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?